Long-term cannabis end users are in danger for acquiring cannabinoid hyperemesis syndrome (CHS), characterised by recurrent bouts of intense vomiting and abdominal cramping during or in forty eight hours of significant cannabis use.[108] The mechanism at the rear of CHS is poorly comprehended and it is contrary towards the antiemetic Attributes of